Skip to main content
Sadhana Nitrochem Ltd. logo

Sadhana Nitrochem Ltd. — Investor Relations & Filings

Ticker · SADHNANIQ ISIN · INE888C01040 BSE.NS Manufacturing
Filings indexed 835 across all filing types
Latest filing 2025-05-02 Regulatory Filings
Country IN India
Listing BSE.NS SADHNANIQ

About Sadhana Nitrochem Ltd.

https://www.sncl.com

Sadhana Nitrochem Ltd. specializes in the manufacture of chemical intermediates and performance chemicals. The company's core product portfolio includes nitrobenzene and its downstream derivatives such as metanilic acid, aniline 2,5 disulphonic acid, and sodium meta nitrobenzene sulphonate. These products serve as critical raw materials for the global dyes, pigments, pharmaceuticals, and agrochemicals sectors. The company operates advanced manufacturing facilities focused on high-purity chemical synthesis and process optimization. Its technical capabilities extend to specialized chemical reactions including nitration, hydrogenation, and sulfonation. By maintaining a vertically integrated production model, the company ensures consistent quality and supply chain reliability for its international client base across various industrial applications.

Recent filings

Filing Released Lang Actions
Outcome of the Board Meeting held on May 02, 2025
Regulatory Filings
2025-05-02 English
Dividend
Regulatory Filings
2025-05-02 English
Outcome of Board Meeting
Regulatory Filings
2025-05-02 English
Outcome of Board Meeting held on May 02, 2025
Regulatory Filings
2025-05-02 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-04-30 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notice dated April 28, 2025, informing stock exchanges about an upcoming Board Meeting scheduled for May 2, 2025. The agenda includes consideration of audited financial results for the quarter and financial year ended March 31, 2025, and dividend recommendation. The document is an intimation or announcement of a board meeting, not the actual financial results or reports. It is short (2354 characters) and serves as a notification to regulators and the market. Therefore, it is best classified as a Regulatory Filing (RNS) since it does not contain the financial results themselves but announces the meeting where such results will be considered.
2025-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.